查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840267

2025年全球醫療保健奈米技術市場報告

Healthcare Nanotechnology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，醫療保健奈米技術市場發展迅速，預計從2024年的3,442.3億美元成長到2025年的3,860.1億美元，複合年成長率達12.1%。過去一段時間的成長可歸因於奈米材料、奈米醫學研究、監管支持、研發投資和奈米結構生物材料的進步。

預計未來幾年，醫療保健奈米技術市場將快速成長，到2029年市場規模將達到7,078.1億美元，複合年成長率（CAGR）為16.4%。預測期內的成長可歸因於治療診斷學、基因治療奈米顆粒、生物相容性奈米材料、奈米手術器械、奈米級療法以及全球衛生應急準備等領域的進展。預測期內的關鍵趨勢包括診斷奈米設備、生物感測器和成像、奈米機器人和奈米手術、個人化醫療以及公眾意識和教育。

醫療奈米技術是指將奈米技術與藥物和診斷分子結合，以改善特定細胞和組織功能的科學領域。這些材料在奈米尺度上製造，可安全注射到體內。奈米技術能夠顯著改善醫療診斷，使其更經濟、更便利。

醫療奈米技術主要分為有機奈米技術、無機奈米技術和碳基奈米技術。醫療奈米技術應用於多種疾病的治療，包括循環系統、腫瘤、神經系統疾病、整形外科和感染疾病。其主要應用領域包括藥物傳遞、生醫材料、活性植入和組織再生。

美國在2025年春季突然提高關稅及其引發的貿易摩擦，對資訊科技產業，特別是硬體製造、資料基礎設施和軟體部署領域，產生了重大影響。進口半導體、電路基板和網路設備的關稅上漲，推高了高科技公司、雲端服務供應商和資料中心的生產和營運成本。在全球範圍內採購筆記型電腦、伺服器和消費電子產品零件的公司，面臨更長的前置作業時間和價格壓力。同時，對專用軟體徵收的關稅以及主要國際市場的報復性措施，擾亂了全球IT供應鏈，並降低了海外對美國製造技術的需求。為了應對這些挑戰，該產業正在加大對國內晶片生產的投資，擴大供應商網路，並利用人工智慧驅動的自動化技術來增強韌性，更有效地控制成本。

本研究報告是商業研究公司（The Business Research Company）全新系列報告的一部分，提供醫療保健奈米技術市場統計數據，例如全球醫療保健奈米技術行業市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的醫療保健奈米技術市場細分、市場趨勢和商業機會，為您提供在醫療保健奈米技術行業取得成功所需的數據。本醫療保健奈米技術市場研究報告透過對產業現狀和未來發展趨勢的詳細分析，為您提供所需的一切觀點。

未來五年16.4%的預測成長率較我們先前對該市場的預測略微下降0.4%。這一下降主要歸因於美國與其他國家之間的關稅影響。由於關稅推高了來自亞洲和歐洲的稀有精密奈米材料的成本，美國奈米技術和醫療保健市場的創新速度可能會放緩。此外，相互關稅以及日益加劇的貿易緊張局勢和限制措施對全球經濟和貿易造成的負面影響也將影響更廣泛的領域。

癌症發病率的上升預計將推動醫療奈米技術市場的成長。奈米技術是一種很有前景的癌症治療方法，有望為包括癌症在內的多種疾病提供更個人化的治療。全球癌症發生率持續上升。例如，美國癌症協會估計，到2023年，美國將新增1,958,310例癌症病例，並有609,820例癌症相關死亡病例。儘管醫療技術和早期檢測方法取得了進步，但這些統計數據凸顯了癌症預防和治療方面仍面臨的持續挑戰。這些數據強調了繼續進行研究和製定有效醫療保健策略以有效對抗癌症的迫切需求。因此，癌症患者數量的增加正在推動醫療奈米技術市場的成長。

糖尿病和肥胖症的日益普及預計將推動醫療奈米技術市場的未來成長。糖尿病是指血糖值過高所引起的疾病，而肥胖症是指肥胖指數達到或超過30。醫療奈米技術提供標靶藥物傳遞和精準醫療方法，用於控制糖尿病和肥胖症，在提高治療效果的同時最大限度地減少副作用。例如，據總部位於比利時的國際糖尿病聯盟（IDF）稱，到2022年6月，全球糖尿病盛行率將上升至10.5%，其中超過一半（44.7%）的患者仍未被確診。 IDF預測，到2045年，將有7.83億人（即八分之一的成年人）患有糖尿病。這將比同期預期的人口成長率（20%）高出46%以上。此外，據總部位於瑞士的世界衛生組織（WHO）稱，到2022年3月，將有6.5億成年人、3.4億青少年和3,900萬名兒童患有肥胖症。世界衛生組織預測，到2025年，將有1.67億成年人和兒童超重或肥胖。因此，糖尿病和肥胖症的增加正在推動醫療保健奈米技術市場的成長。

企業間的策略合作是醫療保健奈米技術市場日益流行的主要趨勢。從事醫療保健奈米技術的公司正在建立聯盟和夥伴關係，以開發新技術和產品。 2022年1月，總部位於美國的醫療保健相關企業NaNotics與梅奧診所合作開發一種名為NaNots的癌症治療方法。在此次合作中，NaNotics將與梅奧診所的研究人員共用其奈米耗竭平台，而梅奧診所將提供其專有的PD-L1抗體和可遞送人源sPD-L1的基因轉殖小鼠模型。梅奧診所是一家總部位於美國的醫療機構，致力於在包括奈米醫學在內的多個醫學領域進行病患治療、教育和研究。

醫療奈米技術市場涵蓋了腫瘤標靶化、藥物傳輸系統和改進型醫學成像營業單位所產生的收入。市場價值包括服務提供者銷售的相關商品或包含在服務產品中的商品價值。僅包括營業單位間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球醫療奈米技術：PESTEL 分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球醫療奈米技術市場：成長率分析
  • 全球醫療保健奈米技術市場表現：規模與成長，2019-2024年
  • 全球醫療保健奈米技術市場預測：規模與成長，2024-2029年，2034年
  • 全球醫療保健奈米技術：潛在市場規模 (TAM)

第6章 市場細分

  • 全球醫療保健奈米技術市場：按疾病、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 心血管疾病
  • 腫瘤性疾病
  • 神經系統疾病
  • 整形外科疾病
  • 感染疾病
  • 全球醫療保健奈米技術市場：按類型、性能和預測，2019-2024年、2024-2029年、2034年
  • 有機的
  • 無機物
  • 碳基
  • 全球醫療保健奈米技術市場：按應用、性能和預測分類，2019-2024年、2024-2029年、2034年
  • 藥物遞送
  • 生物材料
  • 主動植入
  • 組織再生
  • 全球醫療保健奈米技術市場：按心血管疾病類型細分、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 藥物輸送系統
  • 診斷影像
  • 全球醫療保健奈米技術市場：按腫瘤疾病（按類型）細分、性能和預測，2019-2024年、2024-2029年、2034年
  • 標靶藥物遞送
  • 基於奈米顆粒的治療方法
  • 影像診斷
  • 全球醫療奈米技術市場：按神經系統疾病類型細分、性能和預測（2019-2024年、2024-2029年、2034年）
  • 基於奈米顆粒的藥物遞送
  • 診斷工具
  • 全球醫療奈米技術市場：按整形外科疾病類型細分、性能和預測（2019-2024年、2024-2029年、2034年）
  • 骨再生與修復
  • 藥物輸送系統
  • 全球醫療保健奈米技術市場：按感染疾病類型細分、性能和預測（2019-2024 年、2024-2029 年、2034 年）
  • 抗菌奈米材料
  • 疫苗輸送系統

第7章 區域和國家分析

  • 全球醫療保健奈米技術市場：按地區、績效和預測分類，2019-2024年、2024-2029年、2034年
  • 全球醫療保健奈米技術市場：按國家/地區、績效和預測分類，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 醫療保健奈米技術市場：競爭格局
  • 醫療保健奈米技術市場：公司概況
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Teva Pharmaceutical Industries Ltd.
  • Sanofi SA
  • Taiwan Liposome Company Ltd.
  • GE Healthcare Technologies Inc.
  • Mallinckrodt plc
  • Leadiant Biosciences
  • Luminex Corporation
  • Bristol-Myers Squibb Company
  • CytImmune Sciences Inc.
  • Nanobiotix
  • Starpharma Holdings Limited
  • Copernicus Therapeutics Inc.
  • NanoCarrier Co. Ltd
  • LiPlasome Pharma ApS
  • Nami Therapeutics Corp.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年醫療保健奈米技術市場：提供新機會的國家
  • 2029年醫療保健奈米技術市場：新興細分市場機會
  • 2029年醫療保健奈米技術市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r21584u

Healthcare nanotechnology refers to the area of science that combines nanotechnology with drugs or diagnostic molecules to improve the performance of specific cells or tissues. These materials are produced on a nanoscale level and are safe to inject into the body. Nanotechnologies can greatly enhance medical diagnostics by making them more affordable and practical.

The main types of healthcare nanotechnology include organic, inorganic, and carbon-based. Healthcare nanotechnology is used for various diseases such as cardiovascular, oncological, neurological, orthopedic, and infectious diseases. The main applications of healthcare nanotechnology include drug delivery, biomaterials, active implants, and tissue regeneration.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The healthcare nanotechnology market research report is one of a series of new reports from The Business Research Company that provides healthcare nanotechnology market statistics, including healthcare nanotechnology industry global market size, regional shares, competitors with healthcare nanotechnology market share, detailed healthcare nanotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare nanotechnology industry. This healthcare nanotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare nanotechnology market size has grown rapidly in recent years. It will grow from $344.23 billion in 2024 to $386.01 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to advancements in nanomaterials, nanomedicine research, regulatory support, investment in research and development, nanostructured biomaterials.

The healthcare nanotechnology market size is expected to see rapid growth in the next few years. It will grow to $707.81 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to theranostics development, nanoparticles for gene therapy, biocompatible nanomaterials, nano-enabled surgical tools, nanoscale therapeutic agents, global health emergency preparedness. Major trends in the forecast period include diagnostic nanodevices, biosensors and imaging, nanorobotics and nanosurgery, personalized medicine, public awareness and education therapeutic applications.

The forecast of 16.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The U.S. nanotech healthcare market may face innovation delays as tariffs increase the cost of rare and precision-engineered nanomaterials from Asia and Europe. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of cancer cases is anticipated to drive the growth of the healthcare nanotechnology market. Nanotechnology represents a promising approach to cancer treatment, offering the potential for more personalized therapies for various diseases, including cancer. The global prevalence of cancer continues to rise. For example, in 2023, the American Cancer Society estimated that there would be 1,958,310 new cancer diagnoses and 609,820 cancer-related deaths in the United States. These statistics underscore the persistent challenges in cancer prevention and treatment, despite advancements in medical technology and early detection methods. They highlight the urgent need for ongoing research and effective healthcare strategies to address cancer effectively. Consequently, the increasing number of cancer cases is fueling the growth of the healthcare nanotechnology market.

Growing incidences of diabetes and obesity are expected to propel the growth of the healthcare nanotechnology market going forward. Diabetes refers to a condition that develops when blood glucose levels are too high, and obesity refers to the condition of having a body mass index of 30 or more. Healthcare nanotechnology offers targeted drug delivery and precision medicine approaches to manage diabetes and obesity, improving treatment efficacy while minimizing side effects. For instance, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10. 5% worldwide, with over half (44. 7%) of people still undiagnosed. According to IDF predictions, 783 million adults, or one in eight people, will have diabetes by 2045. This would represent a 46% rise, more than double the projected population growth for the same period (20%). Furthermore, in March 2022, according to the World Health Organization, a Switzerland-based agency, 650 million adults, 340 million teenagers, and 39 million children will be obese. This quantity is still rising, and the WHO predicts that by 2025, 167 million adults and children will become overweight or obese. Therefore, growing incidences of diabetes and obesity are driving the growth of the healthcare nanotechnology market.

Strategic collaboration between companies is a key trend gaining popularity in the healthcare nanotechnology market. Companies involved in healthcare nanotechnologies are undergoing partnerships and collaboration to develop new technologies and products. In January 2022, NaNotics, a US-based medical company, collaborated with the Mayo Clinic to develop a cancer treatment known as NaNots. The collaboration will involve NaNotics sharing its nano-depletion platform with Mayo researchers, while the Mayo Clinic will provide its own PD-L1 antibody and a transgenic mouse model that provides human sPD-L1. Mayo Clinic is a US-based clinic dedicated to providing patient care, education, and research in various fields of medicine, including nanomedicine.

Major companies operating in the healthcare nanotechnology market are increasing their focus on introducing nanotechnology-based gel serums to gain a competitive edge in the market. Nanotechnology-based gel serums are products that incorporate nanoscale particles or delivery systems to enhance the absorption and effectiveness of active ingredients. For instance, in March 2023, ENTOD Pharmaceuticals, an India-based healthcare company, launched Eyecirque, a nanotechnology-based under-eye product, in India. Eyecirque is formulated with a cutting-edge, 100% plant-based biocellular composition, featuring vitamin A, C, and E complexes, anti-aging antioxidants, skin-brightening agents, and naturally occurring ultra-moisturizing elements that are rapidly absorbed into the skin around the eyes at a nano-molecular level. It stands as the world's first gel serum of its kind, utilizing nanotechnology to address concerns such as wrinkles, hollowness, hollow eyelids, and dark circles under the eyes.

In January 2024, GenEdit, Inc., a US-based biotechnology firm, announced a multiyear collaboration and licensing agreement with Genentech to develop innovative nanoparticles for the delivery of genetic medicines intended to treat autoimmune diseases. This partnership will utilize GenEdit's NanoGalaxy platform, emphasizing the discovery of hydrophilic nanoparticles (HNPs) for nucleic acid-based therapies. Genentech, also based in the US, is a biotechnology corporation that specializes in healthcare nanotechnology.

Major companies operating in the healthcare nanotechnology market include Pfizer Inc., Johnson & Johnson Inc., Abbott Laboratories, Merck & Company Inc., Union Chimique Belge S. A, Teva Pharmaceutical Industries Ltd., Sanofi SA, Taiwan Liposome Company Ltd., GE Healthcare Technologies Inc., Mallinckrodt plc, Leadiant Biosciences, Luminex Corporation, Bristol-Myers Squibb Company, CytImmune Sciences Inc., Nanobiotix, Starpharma Holdings Limited, Copernicus Therapeutics Inc., NanoCarrier Co. Ltd, LiPlasome Pharma ApS, Nami Therapeutics Corp., Nanospectra Biosciences Inc., Spago Nanomedical AB, Nanobiosym Inc., Nanoviricides Inc., Nanosys Inc., Nanocarrier Co. Ltd., Nanocyl SA, Nanogen Pvt. Ltd.

North America was the largest region in the healthcare nanotechnology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the healthcare nanotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the healthcare nanotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The healthcare nanotechnology market includes revenues earned by entities by targeting tumors, in drug delivery systems, and improving medical imaging. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Nanotechnology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare nanotechnology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for healthcare nanotechnology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The healthcare nanotechnology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Disease: Cardiovascular Diseases; Oncological Diseases; Neurological Diseases; Orthopedic Diseases; Infectious Diseases
  • 2) By Type: Organic; Inorganic; Carbon-Based
  • 3) By Application: Drug Delivery; Biomaterials; Active Implants; Tissue Regeneration
  • Subsegments:
  • 1) By Cardiovascular Diseases: Drug Delivery Systems; Diagnostic Imaging
  • 2) By Oncological Diseases: Targeted Drug delivery; Nanoparticle-Based Therapies; Imaging And Diagnostics
  • 3) By Neurological Diseases: Nanoparticle-Based Drug Delivery; Diagnostic Tools
  • 4) By Orthopedic Diseases: Bone regeneration And Repair; Drug Delivery Systems
  • 5) By Infectious Diseases: Antimicrobial Nanomaterials; Vaccine Delivery Systems
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc.; Abbott Laboratories; Merck & Company Inc.; Union Chimique Belge S. A; Teva Pharmaceutical Industries Ltd.; Sanofi SA; Taiwan Liposome Company Ltd.; GE Healthcare Technologies Inc.; Mallinckrodt plc; Leadiant Biosciences; Luminex Corporation; Bristol-Myers Squibb Company; CytImmune Sciences Inc.; Nanobiotix; Starpharma Holdings Limited; Copernicus Therapeutics Inc.; NanoCarrier Co. Ltd; LiPlasome Pharma ApS; Nami Therapeutics Corp.; Nanospectra Biosciences Inc.; Spago Nanomedical AB; Nanobiosym Inc.; Nanoviricides Inc.; Nanosys Inc.; Nanocarrier Co. Ltd.; Nanocyl SA; Nanogen Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Healthcare Nanotechnology Market Characteristics

3. Healthcare Nanotechnology Market Trends And Strategies

4. Healthcare Nanotechnology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Healthcare Nanotechnology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Healthcare Nanotechnology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Healthcare Nanotechnology Market Growth Rate Analysis
  • 5.4. Global Healthcare Nanotechnology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Healthcare Nanotechnology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Healthcare Nanotechnology Total Addressable Market (TAM)

6. Healthcare Nanotechnology Market Segmentation

  • 6.1. Global Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Diseases
  • Oncological Diseases
  • Neurological Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • 6.2. Global Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Organic
  • Inorganic
  • Carbon-Based
  • 6.3. Global Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery
  • Biomaterials
  • Active Implants
  • Tissue Regeneration
  • 6.4. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Cardiovascular Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Delivery Systems
  • Diagnostic Imaging
  • 6.5. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Oncological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Drug delivery
  • Nanoparticle-Based Therapies
  • Imaging And Diagnostics
  • 6.6. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Neurological Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nanoparticle-Based Drug Delivery
  • Diagnostic Tools
  • 6.7. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Orthopedic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bone regeneration And Repair
  • Drug Delivery Systems
  • 6.8. Global Healthcare Nanotechnology Market, Sub-Segmentation Of Infectious Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antimicrobial Nanomaterials
  • Vaccine Delivery Systems

7. Healthcare Nanotechnology Market Regional And Country Analysis

  • 7.1. Global Healthcare Nanotechnology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Healthcare Nanotechnology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Healthcare Nanotechnology Market

  • 8.1. Asia-Pacific Healthcare Nanotechnology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Healthcare Nanotechnology Market

  • 9.1. China Healthcare Nanotechnology Market Overview
  • 9.2. China Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Healthcare Nanotechnology Market

  • 10.1. India Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Healthcare Nanotechnology Market

  • 11.1. Japan Healthcare Nanotechnology Market Overview
  • 11.2. Japan Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Healthcare Nanotechnology Market

  • 12.1. Australia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Healthcare Nanotechnology Market

  • 13.1. Indonesia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Healthcare Nanotechnology Market

  • 14.1. South Korea Healthcare Nanotechnology Market Overview
  • 14.2. South Korea Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Healthcare Nanotechnology Market

  • 15.1. Western Europe Healthcare Nanotechnology Market Overview
  • 15.2. Western Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Healthcare Nanotechnology Market

  • 16.1. UK Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Healthcare Nanotechnology Market

  • 17.1. Germany Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Healthcare Nanotechnology Market

  • 18.1. France Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Healthcare Nanotechnology Market

  • 19.1. Italy Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Healthcare Nanotechnology Market

  • 20.1. Spain Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Healthcare Nanotechnology Market

  • 21.1. Eastern Europe Healthcare Nanotechnology Market Overview
  • 21.2. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Healthcare Nanotechnology Market

  • 22.1. Russia Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Healthcare Nanotechnology Market

  • 23.1. North America Healthcare Nanotechnology Market Overview
  • 23.2. North America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Healthcare Nanotechnology Market

  • 24.1. USA Healthcare Nanotechnology Market Overview
  • 24.2. USA Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Healthcare Nanotechnology Market

  • 25.1. Canada Healthcare Nanotechnology Market Overview
  • 25.2. Canada Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Healthcare Nanotechnology Market

  • 26.1. South America Healthcare Nanotechnology Market Overview
  • 26.2. South America Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Healthcare Nanotechnology Market

  • 27.1. Brazil Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Healthcare Nanotechnology Market

  • 28.1. Middle East Healthcare Nanotechnology Market Overview
  • 28.2. Middle East Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Healthcare Nanotechnology Market

  • 29.1. Africa Healthcare Nanotechnology Market Overview
  • 29.2. Africa Healthcare Nanotechnology Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Healthcare Nanotechnology Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Healthcare Nanotechnology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Healthcare Nanotechnology Market Competitive Landscape And Company Profiles

  • 30.1. Healthcare Nanotechnology Market Competitive Landscape
  • 30.2. Healthcare Nanotechnology Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck & Company Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Union Chimique Belge S. A Overview, Products and Services, Strategy and Financial Analysis

31. Healthcare Nanotechnology Market Other Major And Innovative Companies

  • 31.1. Teva Pharmaceutical Industries Ltd.
  • 31.2. Sanofi SA
  • 31.3. Taiwan Liposome Company Ltd.
  • 31.4. GE Healthcare Technologies Inc.
  • 31.5. Mallinckrodt plc
  • 31.6. Leadiant Biosciences
  • 31.7. Luminex Corporation
  • 31.8. Bristol-Myers Squibb Company
  • 31.9. CytImmune Sciences Inc.
  • 31.10. Nanobiotix
  • 31.11. Starpharma Holdings Limited
  • 31.12. Copernicus Therapeutics Inc.
  • 31.13. NanoCarrier Co. Ltd
  • 31.14. LiPlasome Pharma ApS
  • 31.15. Nami Therapeutics Corp.

32. Global Healthcare Nanotechnology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Nanotechnology Market

34. Recent Developments In The Healthcare Nanotechnology Market

35. Healthcare Nanotechnology Market High Potential Countries, Segments and Strategies

  • 35.1 Healthcare Nanotechnology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Healthcare Nanotechnology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Healthcare Nanotechnology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer